January 22, 2026: Gastroparesis Lawsuits Progressing While a lot of attention in recent months has been devoted to the emerging vision loss litigation, gastroparesis lawsuits involving Ozempic and other GLP-1s are still progressing
Cardiovascular diseases (CVDs), the leading cause of mortality worldwide, remain inadequately managed by traditional therapies, but biologics offer a paradigm shift from symptom control to disease modification
Much of the current evidence comes from animal studies, observational data, or small human studies
La L-carnitina es un derivado del aminocido que interviene en los mecanismos energticos del organismo
A prospective, randomized, controlled proof-of-concept study in bowel resection patients investigated ipamorelin 0.03 mg/kg administered twice daily for up to 7 days
P.MartinS